Overview

A Study to Compare the Pharmacokinetic Characteristics of CJ-12420

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
To compare the pharmacokinetics after administration of different formulation of CJ-12420
Phase:
Phase 1
Details
Lead Sponsor:
CJ HealthCare Corporation
HK inno.N Corporation